Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
The COVID-19 pandemic is an ongoing global pandemic of coronavirus disease 2019 as an atypical type of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many potential pharmacotherapies are currently being investigated against this disease. This article points t...
Saved in:
Main Authors: | Amani E. Khalifa, PhD, Asser I. Ghoneim, PhD, PharmD |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c9c5eb814fe3485b97f0ef66eb4600a3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021) -
PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019) -
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
by: Anastazja M. Gorecki, et al.
Published: (2021) -
Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
by: Kei Amemiya, et al.
Published: (2021) -
REGULATION OF TLR/RLR GENE ACTIVITY AND SYNTHESIS OF CYTOKINES DURING PHORBOL MYRISTATE ACETATE (PMA)-INDUCED DIFFERENTIATION OF THP-1 MONOCYTES INTO MACROPHAGE-LIKE CELLS
by: T. M. Sokolova, et al.
Published: (2017)